Funds and prices
Overview
The fund invests in equities of major Swiss companies that are included in the SLI.
The fund holds all stocks in the SLI. Individual stocks are held in proportion to the free-float market capitalization of the index.
Diversification is achieved via a mix of sectors and thus offers the investor an optimized risk/return profile.
The investment objective is to generate a performance in line with that of the benchmark, keeping the Tracking Error below the maximum of 0.3% over a rolling period of 3 years.
No investments in securities on the recommendation list for the exclusion of SVVK-ASIR (www.svvk-asir.ch) and controversial weapons.
Benefits
Easy access to the Swiss stock market.
Optimised risk/return profile thanks to a broad diversification across a range of sectors.
Provides access to the performance of the index with a single transaction.
The fund is transparent and cost-effective and is liquid under normal market conditions.
You do not pay any federal stamp duty.
Risks
Features
Product category |
ÃÛ¶¹ÊÓƵ Equity Funds
ÃÛ¶¹ÊÓƵ Index Funds Equities |
Product domicile |
Switzerland
|
Portfolio management |
ÃÛ¶¹ÊÓƵ Asset Management Switzerland AG, Zurich
|
Fund management |
ÃÛ¶¹ÊÓƵ Fund Management (Switzerland) AG
|
Custodian bank |
ÃÛ¶¹ÊÓƵ Switzerland AG, Zurich
|
Day of inception |
November 29, 2017
|
Currency of account |
CHF
|
Close of financial year |
September 30
|
Issue / redemption |
daily
|
Distribution |
Reinvestment
|
Maturity |
Open end
|
Management fee |
0.14% p.a.
|
Total expense ratio (TER) |
0.19% p.a.
|
Minimum investment |
n.a.
|
Reference Index / Benchmark |
SLI Swiss Leader Index® (TR)
|
Securities no. |
38955094
|
ISIN |
CH0389550945
|
Bloomberg Ticker |
ÃÛ¶¹ÊÓƵSPLW SW
|
Performance and Prices
Percentage growth
as of April 3, 2024CHF(%) | EUR(%) | USD(%) | |
YTD | 8.36 | 2.76 | 0.68 |
1M | |||
3M | |||
6M | |||
1Y | |||
2Y | 11.49 | 18.41 | 22.56 |
3Y | |||
5Y | 49.06 | 70.21 | 64.04 |
ø p.a.5Y | 8.31 | 11.22 | 10.40 |
Current data
Net asset value | 03.04.2024 | CHF 146.22 |
High - last 12 months | 28.03.2024 | CHF 147.33 |
Low - last 12 months | 27.10.2023 | CHF 123.69 |
Total product assets in mn | 03.04.2024 | CHF 1,494.22 |
Date
|
2 years
|
5 years
|
|
Total risk reference index / benchmark | 29.02.2024 | 14.90% | 14.59% |
Sharpe Ratio | 29.02.2024 | 0.08 | 0.57 |
Risk Free Rate | 31.03.2024 | 0.87% | -0.06% |
Structures
By the 10 largest positions (in %, as of February 29, 2024)
|
|
Cie Financiere Richemont SA | 9.51 |
Novartis AG | 8.86 |
Nestle SA | 7.77 |
Roche Holding AG | 7.76 |
ABB Ltd | 4.79 |
Alcon Inc | 4.73 |
Holcim Ltd | 4.64 |
Zurich Insurance Group AG | 4.36 |
Sika AG | 4.34 |
Lonza Group AG | 4.33 |
Fees
Distributions
Authorisations
Literature
Document type
|
Document Language
|
|||
Prospectus |
|
|
||
Key Information Document |
|
|
|
|
Past performance |
|
|
|
|
Previous performance scenario |
|
|
|
|
Swiss Climate Scores Report |
|
|||
ASIP ESG Report |
|
|
|
Document type
|
Document Language
|
|
Annual report |
|
|
Semi-annual report |
|
|
Document type
|
Document Language
|
|||
ÃÛ¶¹ÊÓƵ Funds - Your funds at a glance |
|
|
|
|
Tax list |
|
|
|
|